The enigma of monosomy 7

T Inaba, H Honda, H Matsui - … Journal of the American Society of …, 2018 - ashpublications.org
Since a report of some 50 years ago describing refractory anemia associated with group C
monosomy, monosomy 7 (− 7) and interstitial deletions of chromosome 7 (del (7q)) have …

Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions

W Würfel - Journal of reproductive immunology, 2015 - Elsevier
Granulocyte colony-stimulating factor (G-CSF) belongs to the family of colony-stimulating
factors (CSF). As the name suggests, it was initially identified as being able to target and …

Lower risk for serious adverse events and no increased risk for cancer after PBSC vs BM donation

MA Pulsipher, P Chitphakdithai… - Blood, The Journal …, 2014 - ashpublications.org
We compared serious early and late events experienced by 2726 bone marrow (BM) and
6768 peripheral blood stem cell (PBSC) donors who underwent collection of PBSC or BM …

G-CSF in healthy allogeneic stem cell donors

K Hölig - Transfusion Medicine and Hemotherapy, 2013 - karger.com
Mobilization of peripheral blood stem cells (PBSC) in healthy volunteers with granulocyte
colony-stimulating factor (G-CSF) is currently carried out at many institutions worldwide. This …

Hematopoietic stem cell donation

SH Chen, TF Wang, KL Yang - International journal of hematology, 2013 - Springer
Allogeneic hematopoietic stem cell transplantation is now an important treatment for
numerous diseases. Donation of hematopoietic stem cells, either through bone marrow (BM) …

A review of the genetic and long-term effects of G-CSF injections in healthy donors: a reassuring lack of evidence for the development of haematological malignancies

BE Shaw, DL Confer, W Hwang… - Bone marrow …, 2015 - nature.com
In 2007 the WMDA responded to the publication of two manuscripts suggesting a causal link
between G-CSF and myeloid malignancies in healthy donors by convening an international …

Allogeneic hematopoietic stem cell donation—standardized assessment of donor outcome data: A consensus statement from the Worldwide Network for Blood and …

JP Halter, SM Van Walraven, N Worel… - Bone marrow …, 2013 - nature.com
The number of allogeneic hematopoietic SCTs performed globally each year continues to
increase, paralleled by an increased demand for donors of therapeutic cells. Donor …

Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee

RN Lown, J Philippe, W Navarro… - Bone marrow …, 2014 - nature.com
Abstract The World Marrow Donor Association (WMDA) fosters collaboration between
international registries to facilitate the exchange of hematopoietic stem cell products for …

A review of the haematopoietic stem cell donation experience: is there room for improvement?

A Billen, JA Madrigal, BE Shaw - Bone marrow transplantation, 2014 - nature.com
Donation of haematopoietic stem cells, either through BM or PBSC collection, is a generally
safe procedure for healthy donors although adverse reactions are a definite risk. The …

Safety and efficacy of healthy volunteer stem cell mobilization with filgrastim G‐CSF and mobilized stem cell apheresis: results of a prospective longitudinal 5‐year …

MM Mueller, H Bialleck, B Bomke, S Brauninger… - Vox …, 2013 - Wiley Online Library
Background and Objectives G‐CSF‐mobilized peripheral blood stem cells have long
replaced marrow as the major source for allogeneic transplants. Conclusive evidence …